BIODESIX INC — Director's Dealing 2020

Oct 28, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-10-27

Reporting Person: Pestano Gary Anthony (Chief Development Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$3.33	2022-04-26	Common Stock (3369)		Direct
Stock Options (Right to buy)	$4.40	2025-04-08	Common Stock (5053)		Direct
Stock Options (Right to buy)	$0.84	2026-04-06	Common Stock (25269)		Direct
Stock Options (Right to buy)	$0.84	2026-04-06	Common Stock (6191)		Direct
Stock Options (Right to buy)	$0.84	2026-10-13	Common Stock (1903)		Direct
Stock Options (Right to buy)	$0.42	2027-05-15	Common Stock (16846)		Direct
Stock Options (Right to buy)	$0.42	2028-04-03	Common Stock (21058)		Direct
Stock Options (Right to buy)	$4.46	2027-12-31	Common Stock (20206)		Direct
Stock Options (Right to buy)	$4.46	2027-12-31	Common Stock (10260)		Direct
Stock Options (Right to buy)	$0.78	2028-12-31	Common Stock (28639)		Direct
Stock Options (Right to buy)	$0.78	2030-04-14	Common Stock (23585)		Direct

Footnotes

F1: This option vested 40% on March 19, 2014, and the remaining 60% in 36 successive, equal monthly installments measured from March 19, 2014.

F2: This option vested in 60 successive, equal monthly installments measured from January 1, 2015.

F3: This option vests in 60 successive, equal monthly installments measured from January 1, 2016.

F4: This option vests in 60 successive, equal monthly installments measured from January 1, 2017.

F5: This option vests in 60 successive, equal monthly installments measured from January 1, 2018.

F6: This option vests twenty-one sixtieths (21/60ths) on October 1, 2020, the remaining balance vests in 39 successive, equal monthly installments measured from October 1, 2020.

F7: This option vests in 60 successive, equal monthly installments measured from January 1, 2020.